INSIGHTS ON DRUG DEVELOPMENT

• Complementary Methodologies For Analysis Of NISTmAb Impurities

  Gain insight into how SEC and CE‑SDS complement each other to assess monoclonal antibody size variants, offering stronger insight into aggregates, fragments, and overall purity.

• mTOR Pathway

  Explore the mTOR signaling pathway and reveal how mTORC1 regulates cell growth, metabolism, and survival to ensure cellular function and adaptation to environmental cues.

• ADC Development Grows More Complex — SPR Insights Bring Clarity

  Explore how real-time kinetic analysis reveals how conjugation, linker chemistry, and drug loading influence antibody–antigen interactions, while enabling sensitive detection of anti-drug antibodies.

• Mammalian Expression

  See how a biotechnology company advanced an engineered protein therapeutic while navigating development, regulatory, and scalability challenges. 

• Don't Intensify Blindly: Preventing Fouling And Restoring Performance With Targeted Cleaning Of Protein A Resins

  8/27/2026

  Protein A chromatography intensification can increase productivity, but it may also affect process robustness. Explore key tradeoffs, operational challenges, and practical considerations.

• Advancing The Human Liver-Chip Toward FDA Qualification

  9/30/2026

  Explore how human-relevant liver models can improve DILI risk assessment and support stronger development decisions while advancing toward regulatory qualification and scaling into automated studies.

• A Case Study Of The GLP-1 Receptor Agonist, Semaglutide, In Plasma

  7/31/2025

  Light scattering reveals critical insights into the structural integrity, aggregation, and stability of GLP-1 analogs, which are essential for optimizing drug formulations and improving treatments.

• Solid Formulation: Spray Drying Process

  7/24/2025

  Transform your pharmaceutical development with an innovative spray drying technology that enhances API solubility to improve drug bioavailability and formulation performance.

• Safety First: Considerations When Formulating High Potency Compounds

  9/23/2026

  Developing highly potent APIs comes with unique challenges. Explore strategies for managing risk, protecting personnel, and advancing programs with confidence.